Physicochemical Properties
| Molecular Formula | C8H9NO4 |
| Molecular Weight | 183.163 |
| Exact Mass | 183.053 |
| CAS # | 72835-26-8 |
| PubChem CID | 227681 |
| Appearance | White to light yellow solid powder |
| Density | 1.307g/cm3 |
| Boiling Point | 298.2ºC at 760 mmHg |
| Flash Point | 134.1ºC |
| Index of Refraction | 1.514 |
| LogP | -0.1 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 4 |
| Heavy Atom Count | 13 |
| Complexity | 264 |
| Defined Atom Stereocenter Count | 0 |
| InChi Key | YXEWPGYLMHXLPS-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C8H9NO4/c1-2-8(12)13-5-9-6(10)3-4-7(9)11/h3-4H,2,5H2,1H3 |
| Chemical Name | (2,5-dioxopyrrol-1-yl)methyl propanoate |
| Synonyms | NSC 19630; NSC-19630; NSC19630 |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | Saos-2-His273 cells with p53 mutation growth measured by MIRA-1 (25 μM; 48 hr) [1]. Mutant p53 and MIRA-1 (5 μM; 48 hours) both limit cell proliferation [1]. While MIRA-1 (10 μM; 48 hours) much less effectively inhibits p5 3 Saos-2 cells, it dramatically decreases the number of colonies in Saos-2 cells expressing his273 [1]. The fraction of Saos-2 and Saos-2-his273 cells with sub-g1 DNA content increases significantly when mutant p53 is present [1]. MIRA-1 (5 and 10 μM; 24 hours) Transduces SKOV-His175 Cells Cell Proliferation Assay |
| Cell Assay |
Cell Proliferation Assay Cell Types: Saos-2-His273, H1299-His175, SKOV-His175 and SKOV-His273[1] Tested Concentrations: 25 μM Incubation Duration: 48 hrs (hours) Experimental Results: Inhibited cell expression of EGFP, MDM2 and Bax[1]. It grows in a mutant p53-dependent manner, with a survival rate of 18.5~39% without doxycycline and a survival rate of 71.5~87.5% with doxycycline. Apoptosis analysis Cell Types: Saos-2 and Saos-2-His273 cells [1] Tested Concentrations: 10 μM Incubation Duration: 48 hrs (hours) Experimental Results: In the presence of the mutant, results in a substantial increase in the fraction of cells with sub-G1 DNA content Section 53 pages. |
| References |
[1]. Reactivation of mutant p53 and induction of apoptosis in human tumor cells by maleimide analogs [published correction appears in J Biol Chem. 2017 Dec 1;292(48):19607]. J Biol Chem. 2005;280(34):30384-30391. |
Solubility Data
| Solubility (In Vitro) | DMSO : ~100 mg/mL (~545.97 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (13.65 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (13.65 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 2.5 mg/mL (13.65 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 5.4597 mL | 27.2985 mL | 54.5971 mL | |
| 5 mM | 1.0919 mL | 5.4597 mL | 10.9194 mL | |
| 10 mM | 0.5460 mL | 2.7299 mL | 5.4597 mL |